Risk factors

Lipid and CVD risk screening needed for all patients with endocrine diseases

New guidelines from the Endocrine Society address the information gap regarding dyslipidemia screening and cardiovascular risk assessment and management in endocrine diseases beyond diabetes and obesity. The guidelines, published in The Journal of Clinical Endocrinology & Metabolism, also provide recommendations on lipid management in thyroid disease, Cushing’s syndrome, disorders of growth hormone secretion, PCOS, menopause, ...

Already a member?

Login to keep reading.

© 2021 the limbic